Ohta S - Search Results

1

Effects of new endogenous nonprotein amino acids, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives, on behavior of mice.

Nakagawa H, Nihonmatsu N, Ohta S, Hirobe M. Nakagawa H, et al. Among authors: ohta s. Biochem Biophys Res Commun. 1996 Aug 23;225(3):1027-34. doi: 10.1006/bbrc.1996.1289. Biochem Biophys Res Commun. 1996. PMID: 8780728

2

Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.

Kawai H, Makino Y, Hirobe M, Ohta S. Kawai H, et al. Among authors: ohta s. J Neurochem. 1998 Feb;70(2):745-51. doi: 10.1046/j.1471-4159.1998.70020745.x. J Neurochem. 1998. PMID: 9453570 Free article.

3

Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies.

Kotake Y, Tasaki Y, Hirobe M, Ohta S. Kotake Y, et al. Among authors: ohta s. Brain Res. 1998 Mar 23;787(2):341-3. doi: 10.1016/s0006-8993(97)01560-6. Brain Res. 1998. PMID: 9518683

4

Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain.

Kohno M, Ohta S, Hirobe M. Kohno M, et al. Among authors: ohta s. Biochem Biophys Res Commun. 1986 Oct 15;140(1):448-54. doi: 10.1016/0006-291x(86)91111-3. Biochem Biophys Res Commun. 1986. PMID: 3778459

5

1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.

Kotake Y, Tasaki Y, Makino Y, Ohta S, Hirobe M. Kotake Y, et al. Among authors: ohta s. J Neurochem. 1995 Dec;65(6):2633-8. doi: 10.1046/j.1471-4159.1995.65062633.x. J Neurochem. 1995. PMID: 7595560

6

A novel metabolite of 3,4-methylenedioxyamphetamine (MDA): formation of 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline and its pharmacological effect.

Nakagawa H, Makino Y, Yoshida Y, Ohta S, Hirobe M. Nakagawa H, et al. Among authors: ohta s. Biol Pharm Bull. 1993 Jun;16(6):579-82. doi: 10.1248/bpb.16.579. Biol Pharm Bull. 1993. PMID: 8364510 Free article.

7

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

Tasaki Y, Makino Y, Ohta S, Hirobe M. Tasaki Y, et al. Among authors: ohta s. J Neurochem. 1991 Dec;57(6):1940-3. doi: 10.1111/j.1471-4159.1991.tb06407.x. J Neurochem. 1991. PMID: 1940911

8

Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.

Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S. Kotake Y, et al. Among authors: ohta s. Neurosci Lett. 1996 Oct 11;217(1):69-71. doi: 10.1016/0304-3940(96)13065-2. Neurosci Lett. 1996. PMID: 8905742

9

Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization.

Makino Y, Tasaki Y, Ohta S, Hirobe M. Makino Y, et al. Among authors: ohta s. Biomed Environ Mass Spectrom. 1990 Jul;19(7):415-9. doi: 10.1002/bms.1200190706. Biomed Environ Mass Spectrom. 1990. PMID: 2205314

10

Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.

Ohta S, Tachikawa O, Makino Y, Tasaki Y, Hirobe M. Ohta S, et al. Life Sci. 1990;46(8):599-605. doi: 10.1016/0024-3205(90)90128-e. Life Sci. 1990. PMID: 2308469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,238 results

Search Page

Filters